首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药防风抗肝癌作用及机制的网络药理学和细胞实验研究
引用本文:侯文跃,姚霏,庄耀隆,张露蓉.中药防风抗肝癌作用及机制的网络药理学和细胞实验研究[J].中国医院药学杂志,2022,42(21):2238-2243.
作者姓名:侯文跃  姚霏  庄耀隆  张露蓉
作者单位:1. 南京中医药大学附属苏州市中医医院中心实验室, 江苏 苏州 215009;2. 苏州市吴门医派研究院中药研究与开发部, 江苏 苏州 215009
基金项目:2020年江苏省卫生健康委医学科项目(编号:M2020004);2021年度苏州市科技发展计划(医疗卫生创新)项目(编号:SKJY2021132);2020年度苏州市科技发展计划(民生科技)项目(编号:SYS2020188)
摘    要:目的: 应用网络药理学和细胞实验,探究中药防风提取液的抗肝癌效应及可能机制,为防风在抗肝癌的临床应用提供依据。方法: 应用网络药理学方法筛选防风抗肝癌的有效成分及相应靶点,并建立"药物-成分-靶点"可视化网络;采用富集分析筛选信号通路;利用Autodock Vina软件验证效应成分与肝癌相关靶点结合力,MTT法测定细胞增殖率,流式细胞术检测细胞凋亡率,Western blot检测相关蛋白表达。结果: 通过多种数据库共筛选得到防风抗肝癌的15种有效成分和AKT1、CASP3、TP53、JUN、IL-6前5个核心靶点基因。富集分析显示细胞凋亡通路尤为集中。前5位的有效成分与核心靶点对接,结果显示其结合能均小于-20.92 kJ·mol-1。与空白对照组比较,24和48 h时防风提取液对HepG-2细胞的抑制率随浓度升高而增大;细胞凋亡率亦升高;同时促使Caspase-3蛋白磷酸化,提高Bax/Bcl-2比值。结论: 防风提取液可抑制人肝癌细胞 HepG-2 的增殖,诱导人肝癌细胞 HepG-2凋亡,且呈剂量、时间依赖性,其作用机制可能是通过上调HepG-2细胞内Bax蛋白表达、下调Bcl-2蛋白并促进Caspase-3蛋白磷酸化发挥作用。

关 键 词:防风  肝癌  效应与机制  网络药理学  细胞实验  
收稿时间:2022-05-05

Network pharmacological and cellular experimental studies on the antihepatoma effect and mechanism of traditional Chinese medicine Saposhnikoviae Radix
HOU Wen-yue,YAO Fei,ZHUANG Yao-long,ZHANG Lu-rong.Network pharmacological and cellular experimental studies on the antihepatoma effect and mechanism of traditional Chinese medicine Saposhnikoviae Radix[J].Chinese Journal of Hospital Pharmacy,2022,42(21):2238-2243.
Authors:HOU Wen-yue  YAO Fei  ZHUANG Yao-long  ZHANG Lu-rong
Institution:1. Central Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangsu Suzhou 215009, China;2. Research and Development Department of Traditional Chinese Medicine, Suzhou Academy of Wumen Chinese Medicine, Jiangsu Suzhou 215009, China
Abstract:OBJECTIVE To explore the effect and possible mechanism of Saposhnikoviae Radix extract on hepatocellular carcinoma by using network pharmacology and cell experiment, so as to provide basis for the clinical application of Saposhnikoviae Radixin to anti hepatocellular carcinoma.METHODS The effective components and corresponding targets of Saposhnikoviae Radix for anti hepatocellular carcinoma were screened by network pharmacology, and the "drug-component-target" visual network was established. The apoptosis pathway was screened by enrichment analysis. Autodock Vina software was used to verify the binding force between the effective components and hepatocellular carcinoma related targets. The cell proliferation rate was measured by MTT assay. The apoptosis rate was detected by flow cytometry, and the expression of related proteins was detected by Western blot.RESULTS Fifteen active components and five target genes of AKT1, CASP3, TP53, JUN and IL-6 of Saposhnikoviae Radix for anti hepatocellular carcinoma were screened through a variety of databases. The results showed that the binding energy of the first five active components was less than20.92 kJ·mol-1. Compared with that of the blank control group, the inhibition rate of Saposhnikoviae Radix extract on HepG-2 cells increased with the concentration increase at 24h and 48h; the apoptosis rate also increased; at the same time, it promoted the phosphorylation of Caspase-3 protein and increased the ratio of Bax/Bcl-2.CONCLUSION Saposhnikoviae Radix extract can inhibit the proliferation of human hepatoma cell line HepG-2 and induce the apoptosis of human hepatoma cell line HepG-2 in a concentrationand time-dependent manner. Its mechanism may be related to up-regulating the expression of Bax protein in HepG-2 cells, down-regulating Bcl-2 protein and promoting the phosphorylation of Caspase-3 protein.
Keywords:Saposhnikoviae Radix  hepatocellular carcinoma  effect and mechanism  network pharmacology  cell experiment  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号